Skip to main content
Erschienen in: Journal of NeuroVirology 2/2019

10.01.2019

Impact of infection on risk of Parkinson’s disease: a quantitative assessment of case-control and cohort studies

verfasst von: Lei Meng, Liang Shen, Hong-Fang Ji

Erschienen in: Journal of NeuroVirology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Identifying modifiable risk factors for Parkinson’s disease (PD) to help prevent this disease has attracted increasing interest in recent years for the limited effective drugs at present. Despite many studies indicated that infection acts as a risk factor for PD, there is no quantitative assessment of the impact of viral and bacterial infections on the risk of developing PD. The present study performed a meta-analysis on the basis of 38 datasets from 13 studies covering 287,773 PD cases and 7,102,901 controls to ascertain the association between PD and infection and the differences in the strength of the viral and bacterial infections. The overall meta-analytic results indicated that individuals with infection had a 20% increased risk of PD compared with controls (OR 1.20, 95%CI 1.07–1.32). The subgroup analysis according to the type of infection found that bacterial infection had a significant impact on increased risk of PD (OR 1.40, 95%CI 1.32–1.48). The present analysis indicated that infection could increase the risk of developing PD, and physician should be aware of the risk of developing PD in subjects with infection.
Literatur
Zurück zum Zitat Arai H, Furuya T, Mizuno Y, Mochizuki H (2006) Inflammation and infection in Parkinson’s disease. Histol Histopathol 21:673–678PubMed Arai H, Furuya T, Mizuno Y, Mochizuki H (2006) Inflammation and infection in Parkinson’s disease. Histol Histopathol 21:673–678PubMed
Zurück zum Zitat Barcia C, Ros CM, Annese V, Gómez A, Ros-Bernal F, Aguado-Llera D, Martínez-Pagán ME, de Pablos V, Fernandez-Villalba E, Herrero MT (2012) IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson’s disease. Cell Death Dis 3:e379CrossRefPubMedPubMedCentral Barcia C, Ros CM, Annese V, Gómez A, Ros-Bernal F, Aguado-Llera D, Martínez-Pagán ME, de Pablos V, Fernandez-Villalba E, Herrero MT (2012) IFN-gamma signaling, with the synergistic contribution of TNF-alpha, mediates cell specific microglial and astroglial activation in experimental models of Parkinson’s disease. Cell Death Dis 3:e379CrossRefPubMedPubMedCentral
Zurück zum Zitat Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205–214CrossRefPubMed Barnham KJ, Masters CL, Bush AI (2004) Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205–214CrossRefPubMed
Zurück zum Zitat Bras JM, Singleton A (2009) Genetic susceptibility in Parkinson’s disease. Biochim Biophys Acta 1792:597–603CrossRefPubMed Bras JM, Singleton A (2009) Genetic susceptibility in Parkinson’s disease. Biochim Biophys Acta 1792:597–603CrossRefPubMed
Zurück zum Zitat Brown GC (2007) Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35:1119–1121CrossRefPubMed Brown GC (2007) Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35:1119–1121CrossRefPubMed
Zurück zum Zitat Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, Liu CH, Deng B, Yao XQ, Xu ZQ, Zhou HD, Wang YJ (2015) The association between infectious burden and Parkinson’s disease: a case-control study. Parkinsonism Relat Disord 21:877–881CrossRefPubMed Bu XL, Wang X, Xiang Y, Shen LL, Wang QH, Liu YH, Jiao SS, Wang YR, Cao HY, Yi X, Liu CH, Deng B, Yao XQ, Xu ZQ, Zhou HD, Wang YJ (2015) The association between infectious burden and Parkinson’s disease: a case-control study. Parkinsonism Relat Disord 21:877–881CrossRefPubMed
Zurück zum Zitat Carvey PM, Chang QA, Ling Z (2004) Prenatal lipopolysaccharide (LPS) induces permanent reductions in dopamine neurons: effect of epigenetic alterations in CNS inflammatory homeostasis as an animal model for Parkinson's disease. Mov Disord 19:S151CrossRef Carvey PM, Chang QA, Ling Z (2004) Prenatal lipopolysaccharide (LPS) induces permanent reductions in dopamine neurons: effect of epigenetic alterations in CNS inflammatory homeostasis as an animal model for Parkinson's disease. Mov Disord 19:S151CrossRef
Zurück zum Zitat Collier TJ, Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates. Nat Rev Neurosci 12:359–366CrossRefPubMedPubMedCentral Collier TJ, Kanaan NM, Kordower JH (2011) Ageing as a primary risk factor for Parkinson’s disease: evidence from studies of non-human primates. Nat Rev Neurosci 12:359–366CrossRefPubMedPubMedCentral
Zurück zum Zitat Danzer M, Samberger C, Schicho R, Lippe IT, Holzer P (2004) Immunocytochemical characterization of rat brainstem neurons with vagal afferent input from the stomach challenged by acid or ammonia. Eur J Neurosci 19:85–92CrossRefPubMed Danzer M, Samberger C, Schicho R, Lippe IT, Holzer P (2004) Immunocytochemical characterization of rat brainstem neurons with vagal afferent input from the stomach challenged by acid or ammonia. Eur J Neurosci 19:85–92CrossRefPubMed
Zurück zum Zitat De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT (2012) Infectious agents and neurodegeneration. Mol Neurobiol 46:614–638CrossRefPubMedPubMedCentral De Chiara G, Marcocci ME, Sgarbanti R, Civitelli L, Ripoli C, Piacentini R, Garaci E, Grassi C, Palamara AT (2012) Infectious agents and neurodegeneration. Mol Neurobiol 46:614–638CrossRefPubMedPubMedCentral
Zurück zum Zitat Fang F, Wirdefeldt K, Jacks A, Kamel F, Ye W, Chen H (2012) CNS infections, sepsis and risk of Parkinson’s disease. Int J Epidemiol 41:1042–1049CrossRefPubMedPubMedCentral Fang F, Wirdefeldt K, Jacks A, Kamel F, Ye W, Chen H (2012) CNS infections, sepsis and risk of Parkinson’s disease. Int J Epidemiol 41:1042–1049CrossRefPubMedPubMedCentral
Zurück zum Zitat Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM, Stamataki Z, Meredith LW, Rowe IA, Luo G, Lopez-Ramirez MA, Baumert TF, Weksler B, Couraud PO, Kim KS, Romero IA, Jopling C, Morgello S, Balfe P, McKeating JA (2012) Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142:634–643.e6CrossRefPubMed Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM, Stamataki Z, Meredith LW, Rowe IA, Luo G, Lopez-Ramirez MA, Baumert TF, Weksler B, Couraud PO, Kim KS, Romero IA, Jopling C, Morgello S, Balfe P, McKeating JA (2012) Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 142:634–643.e6CrossRefPubMed
Zurück zum Zitat Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM (2008) Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 28:7687–7698CrossRefPubMedPubMedCentral Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM (2008) Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J Neurosci 28:7687–7698CrossRefPubMedPubMedCentral
Zurück zum Zitat Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt J, Factor SA, Payami H (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease. Nat Genet 42:781–785CrossRefPubMedPubMedCentral Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D, Kay DM, Doheny KF, Paschall J, Pugh E, Kusel VI, Collura R, Roberts J, Griffith A, Samii A, Scott WK, Nutt J, Factor SA, Payami H (2010) Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease. Nat Genet 42:781–785CrossRefPubMedPubMedCentral
Zurück zum Zitat Harris MA, Tsui JK, Marion SA, Shen H, Teschke K (2012) Association of Parkinson’s disease with infections and occupational exposure to possible vectors. Mov Disord 27:1111–1117CrossRefPubMed Harris MA, Tsui JK, Marion SA, Shen H, Teschke K (2012) Association of Parkinson’s disease with infections and occupational exposure to possible vectors. Mov Disord 27:1111–1117CrossRefPubMed
Zurück zum Zitat Huang HK, Wang JH, Lei WY, Chen CL, Chang CY, Liou LS (2018) Helicobacter pylori infection is associated with an increased risk of Parkinson’s disease: a population-based retrospective cohort study. Parkinsonism Relat Disord 47:26–31CrossRefPubMed Huang HK, Wang JH, Lei WY, Chen CL, Chang CY, Liou LS (2018) Helicobacter pylori infection is associated with an increased risk of Parkinson’s disease: a population-based retrospective cohort study. Parkinsonism Relat Disord 47:26–31CrossRefPubMed
Zurück zum Zitat Jang H, Boltz DA, Webster RG, Smeyne RJ (2009) Viral Parkinsonism. Biochim Biophys Acta 1792:714–721CrossRefPubMed Jang H, Boltz DA, Webster RG, Smeyne RJ (2009) Viral Parkinsonism. Biochim Biophys Acta 1792:714–721CrossRefPubMed
Zurück zum Zitat Kim JM, Jang ES, Ok K, Oh ES, Kim KJ, Jeon B, Jo HJ, Ki M, Jeong SH (2016) Association between hepatitis C virus infection and Parkinson’s disease. Mov Disord 31:1584–1585CrossRefPubMed Kim JM, Jang ES, Ok K, Oh ES, Kim KJ, Jeon B, Jo HJ, Ki M, Jeong SH (2016) Association between hepatitis C virus infection and Parkinson’s disease. Mov Disord 31:1584–1585CrossRefPubMed
Zurück zum Zitat Lai SW, Lin CH, Lin HF, Lin CL, Lin CC, Liao KF (2017) Herpes zoster correlates with increased risk of Parkinson’s disease in older people: a population-based cohort study in Taiwan. Medicine (Baltimore) 96:e6075CrossRef Lai SW, Lin CH, Lin HF, Lin CL, Lin CC, Liao KF (2017) Herpes zoster correlates with increased risk of Parkinson’s disease in older people: a population-based cohort study in Taiwan. Medicine (Baltimore) 96:e6075CrossRef
Zurück zum Zitat Lema Tomé CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and α-synuclein’s prion-like behavior in Parkinson’s disease – is there a link? Mol Neurobiol 47:561–574CrossRefPubMed Lema Tomé CM, Tyson T, Rey NL, Grathwohl S, Britschgi M, Brundin P (2013) Inflammation and α-synuclein’s prion-like behavior in Parkinson’s disease – is there a link? Mol Neurobiol 47:561–574CrossRefPubMed
Zurück zum Zitat Liu B, Gao HM, Hong JS (2003) Parkinson’s disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 111:1065–1073CrossRefPubMedPubMedCentral Liu B, Gao HM, Hong JS (2003) Parkinson’s disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect 111:1065–1073CrossRefPubMedPubMedCentral
Zurück zum Zitat Martyn CN, Osmond C (1995) Parkinson’s disease and the environment in early life. J Neurol Sci 132(2):201–206CrossRefPubMed Martyn CN, Osmond C (1995) Parkinson’s disease and the environment in early life. J Neurol Sci 132(2):201–206CrossRefPubMed
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269CrossRefPubMed Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151:264–269CrossRefPubMed
Zurück zum Zitat Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B (2012) Treatment for Helicobacter pylori infection and risk of Parkinson’s disease in Denmark. Eur J Neurol 19:864–869CrossRefPubMedPubMedCentral Nielsen HH, Qiu J, Friis S, Wermuth L, Ritz B (2012) Treatment for Helicobacter pylori infection and risk of Parkinson’s disease in Denmark. Eur J Neurol 19:864–869CrossRefPubMedPubMedCentral
Zurück zum Zitat Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Schrag A, Lees A, Goldacre M (2017) Viral hepatitis and Parkinson disease: a national record-linkage study. Neurology 88:1630–1633CrossRefPubMed Pakpoor J, Noyce A, Goldacre R, Selkihova M, Mullin S, Schrag A, Lees A, Goldacre M (2017) Viral hepatitis and Parkinson disease: a national record-linkage study. Neurology 88:1630–1633CrossRefPubMed
Zurück zum Zitat Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatr Clin Neurosci 14:223–236CrossRef Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatr Clin Neurosci 14:223–236CrossRef
Zurück zum Zitat Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590CrossRefPubMed Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 29:1583–1590CrossRefPubMed
Zurück zum Zitat Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64:990–997CrossRefPubMed Ritz B, Ascherio A, Checkoway H, Marder KS, Nelson LM, Rocca WA, Ross GW, Strickland D, Van Den Eeden SK, Gorell J (2007) Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol 64:990–997CrossRefPubMed
Zurück zum Zitat Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674–2679CrossRefPubMed Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR (2000) Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 283:2674–2679CrossRefPubMed
Zurück zum Zitat Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137:47–59CrossRefPubMedPubMedCentral Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG, Gage FH, Glass CK (2009) A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137:47–59CrossRefPubMedPubMedCentral
Zurück zum Zitat Shen CH, Chou CH, Liu FC, Lin TY, Huang WY, Wang YC, Kao CH (2016) Association between tuberculosis and Parkinson disease: a nationwide, population-based cohort study. Medicine (Baltimore) 95:e2883CrossRef Shen CH, Chou CH, Liu FC, Lin TY, Huang WY, Wang YC, Kao CH (2016) Association between tuberculosis and Parkinson disease: a nationwide, population-based cohort study. Medicine (Baltimore) 95:e2883CrossRef
Zurück zum Zitat Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H (1995) The substantia nigra is a major target for neurovirulent influenza a virus. J Exp Med 181:2161–2169CrossRefPubMed Takahashi M, Yamada T, Nakajima S, Nakajima K, Yamamoto T, Okada H (1995) The substantia nigra is a major target for neurovirulent influenza a virus. J Exp Med 181:2161–2169CrossRefPubMed
Zurück zum Zitat Tsai HH, Liou HH, Muo CH, Lee CZ, Yen RF, Kao CH (2016) Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study. Neurology 86:840–846CrossRefPubMed Tsai HH, Liou HH, Muo CH, Lee CZ, Yen RF, Kao CH (2016) Hepatitis C virus infection as a risk factor for Parkinson disease: a nationwide cohort study. Neurology 86:840–846CrossRefPubMed
Zurück zum Zitat Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson’s disease. Nat Med 10(suppl):S58–S62CrossRefPubMed Vila M, Przedborski S (2004) Genetic clues to the pathogenesis of Parkinson’s disease. Nat Med 10(suppl):S58–S62CrossRefPubMed
Zurück zum Zitat Vlajinac H, Dzoljic E, Maksimovic J, Marinkovic J, Sipetic S, Kostic V (2013) Infections as a risk factor for Parkinson’s disease: a case-control study. Int J Neurosci 123:329–332CrossRefPubMed Vlajinac H, Dzoljic E, Maksimovic J, Marinkovic J, Sipetic S, Kostic V (2013) Infections as a risk factor for Parkinson’s disease: a case-control study. Int J Neurosci 123:329–332CrossRefPubMed
Zurück zum Zitat Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H, Berding G (2006) Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 55:1624–1630CrossRefPubMedPubMedCentral Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H, Berding G (2006) Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 55:1624–1630CrossRefPubMedPubMedCentral
Zurück zum Zitat Wu WY, Kang KH, Chen SL, Chiu SY, Yen AM, Fann JC, Su CW, Liu HC, Lee CZ, Fu WM, Chen HH, Liou HH (2015) Hepatitis C virus infection: a risk factor for Parkinson’s disease. J Viral Hepat 22:784–791CrossRefPubMed Wu WY, Kang KH, Chen SL, Chiu SY, Yen AM, Fann JC, Su CW, Liu HC, Lee CZ, Fu WM, Chen HH, Liou HH (2015) Hepatitis C virus infection: a risk factor for Parkinson’s disease. J Viral Hepat 22:784–791CrossRefPubMed
Metadaten
Titel
Impact of infection on risk of Parkinson’s disease: a quantitative assessment of case-control and cohort studies
verfasst von
Lei Meng
Liang Shen
Hong-Fang Ji
Publikationsdatum
10.01.2019
Verlag
Springer International Publishing
Erschienen in
Journal of NeuroVirology / Ausgabe 2/2019
Print ISSN: 1355-0284
Elektronische ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-018-0707-4

Weitere Artikel der Ausgabe 2/2019

Journal of NeuroVirology 2/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.